- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Research
- About
The Biopharmaceutical Sector’s Impact on the Economy of Oklahoma
This fact sheet presents an analysis of the impact of the biopharmaceutical sector on the economy of Oklahoma (OK) in 2008, including data on employment, economic output, and research and development activity. The biopharmaceutical sector’s economic impact includes not only the direct impact of its companies, but also the ripple effects that the sector has throughout the rest of the economy. These ripple effects include both the indirect impact, the economic value of the goods or services used to support biopharmaceutical companies, and the induced impact, the value of the economic activity supported by the spending of the direct and indirect employees of the biopharmaceutical sector.
Additional Information on the Biopharmaceutical Sector’s Impact in Oklahoma:
PhRMA commissioned Battelle to conduct this study to examine the extent to which state governments are targeting the industry for economic growth and development:
- Oklahoma’s biopharmaceutical sector supported nearly 21,000 jobs and contributed $3.4 billion to the economy in 2006, including direct, indirect and induced impacts
- Since 1987, the Oklahoma Center for the Advancement of Science and Technology has invested $138.6 million to support the state’s technology industries, including the biosciences, that has attracted $2.4 billion in private investment and federal funding
- Since 2006, Oklahoma has been working to spur investment in technology development and commercialization of innovative technology in a number of areas, including in the biosciences
*Battelle state fact sheets use the latest data available at the time of publication. This may predate the data from the Archstone reports, which use 2008 data.
